Renafor-B Inhaler is a combination inhaler containing Budesonide and Formoterol Fumarate, designed for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). This inhaler provides a dual approach to respiratory care: Budesonide, an inhaled corticosteroid, reduces airway inflammation, while Formoterol Fumarate, a long-acting beta-2 agonist (LABA), relaxes bronchial muscles to improve airflow and ease breathing.

The combination therapy helps prevent asthma attacks, reduce flare-ups, and improve overall lung function. Budesonide targets the underlying inflammation in the airways, while Formoterol ensures sustained bronchodilation, providing both symptom control and protection against exacerbations. Regular use of Renafor-B can significantly enhance quality of life for patients with persistent asthma or COPD.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each puff of Renafor-B Inhaler contains:

• Budesonide – 80 mcg

• Formoterol Fumarate – 4.5 mcg

Mechanism of Action

Renafor-B Inhaler works through the combined pharmacological actions of its components:

• Budesonide: A corticosteroid that reduces airway inflammation by inhibiting inflammatory cells and mediators, preventing swelling and mucus accumulation in the lungs.

• Formoterol Fumarate: A long-acting beta-2 agonist that relaxes bronchial smooth muscles, causing sustained bronchodilation and improved airflow.

Together, these actions help reduce wheezing, coughing, shortness of breath, and the frequency of asthma or COPD exacerbations.

Indications

Renafor-B Inhaler is indicated for:

• Asthma: For patients requiring maintenance therapy with both anti-inflammatory and bronchodilator effects

• Chronic Obstructive Pulmonary Disease (COPD): For long-term symptom control and prevention of exacerbations

• Management of persistent airway obstruction and prevention of respiratory flare-ups

This inhaler is intended for maintenance therapy and is not suitable for immediate relief of sudden breathing difficulties.

Dosage and Administration

Dosage should be individualized according to patient needs and medical guidance:

• Typical dose: 1–2 puffs twice daily, as prescribed by a healthcare provider

• Shake the inhaler well before use

• Exhale fully before inhaling the medication

• Place the mouthpiece in the mouth, inhale deeply while pressing the canister, and hold the breath for 5–10 seconds

• Rinse the mouth with water after use to reduce the risk of oral thrush caused by Budesonide

Consistent daily use is essential for effective control of symptoms.

Possible Side Effects

Common side effects may include:

• Throat irritation or hoarseness

• Cough

• Dry mouth

• Mild tremors or palpitations

• Headache

Less common but serious side effects may include increased heart rate, allergic reactions, or severe respiratory symptoms. Medical advice should be sought if such symptoms occur.

Precautions and Warnings

Before using Renafor-B Inhaler, patients should consider:

• Inform your doctor about heart disease, high blood pressure, or arrhythmias

• Use caution if you have diabetes, thyroid disorders, or seizures

• Regular monitoring of lung function may be required

• Not suitable as a rescue inhaler for sudden asthma attacks

Use in Pregnancy and Lactation

Renafor-B Inhaler should only be used during pregnancy or breastfeeding if clearly needed and prescribed by a physician. The benefits and potential risks should be carefully evaluated.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 30°C in a dry place

• Keep the inhaler upright and away from direct sunlight

• Keep out of reach of children

Conclusion

Renafor-B Inhaler (Budesonide + Formoterol Fumarate) is an effective combination therapy for long-term management of asthma and COPD. By reducing airway inflammation and providing sustained bronchodilation, it helps prevent flare-ups, improve lung function, and enhance quality of life. Regular use under medical supervision ensures safe and effective control of chronic respiratory conditions.